 |
|
|
| |
Week 96 Renal Safety Update of
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF
from Two Phase 3 Randomized Controlled Trials
|
| |
| |
Reported by Jules Levin
14th European AIDS Conference
16-19 October, 2013
Brussels, Belgium
F Post1, J Winston2, B Hendry1, B Gazzard3, J Molina4,
HC Liu5, D Piontkowsky5, AK Cheng5, MS Rhee5, J Szwarcberg5
1King's College London School of Medicine, London, UK; 2Mount Sinai School of Medicine, New York, US;
3Chelsea and Westminster Hospital, London, UK; 4Saint-Louis Hospital and University of Paris Diderot, Paris, France; 5Gilead Sciences, Foster City, US
|
| |
|
|
|
|
|
